Hemab Therapeutics has concluded an oversubscribed Series C funding round, raising $157m to further develop therapies for ...
MSD has received US FDA approval for an updated indication of Winrevair by injection to treat adults with pulmonary arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback